RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000051.xml
Semin Plast Surg 2016; 30(01): 039-044
DOI: 10.1055/s-0035-1571255
DOI: 10.1055/s-0035-1571255
Spastic Paralysis of the Elbow and Forearm
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
10. Februar 2016 (online)
![](https://www.thieme-connect.de/media/sps/201601/lookinside/thumbnails/10-1055-s-0035-1571255_01078-1.jpg)
Abstract
As the physiologic recovery period concludes, the patient is evaluated for surgical procedures that may rebalance muscle function and correct deformity. Upper extremity function is the product of complex and highly sophisticated mechanisms working in unison, and a careful, systematic preoperative evaluation is critical. A good function of the hand cannot be achieved without adequate position of the shoulder, elbow, forearm, and wrist. The goals of surgery must be practical and clearly understood by the patient and the family.
-
References
- 1 Pandyan AD, Gregoric M, Barnes MP , et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005; 27 (1–2) 2-6
- 2 Nair KP, Marsden J. The management of spasticity in adults. BMJ 2014; 349: g4737
- 3 Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW ; Task Force on Childhood Motor Disorders. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 111 (1) e89-e97
- 4 Narayanan UG. Management of children with ambulatory cerebral palsy: an evidence-based review. J Pediatr Orthop 2012; 32 (Suppl. 02) S172-S181
- 5 Carlson EJ, Carlson MG. Treatment of swan neck deformity in cerebral palsy. J Hand Surg Am 2014; 39 (4) 768-772
- 6 Kent RM. Cerebral palsy. Handb Clin Neurol 2013; 110: 443-459
- 7 Vadivelu S, Stratton A, Pierce W. Pediatric tone management. Phys Med Rehabil Clin N Am 2015; 26 (1) 69-78
- 8 Parziale JR, Akelman E, Herz DA. Spasticity: pathophysiology and management. Orthopedics 1993; 16 (7) 801-811
- 9 Tilton A. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol 2009; 16 (2) 82-89
- 10 Deon LL, Gaebler-Spira D. Assessment and treatment of movement disorders in children with cerebral palsy. Orthop Clin North Am 2010; 41 (4) 507-517
- 11 Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991; 29 (1) 48-64
- 12 Korenkov AI, Niendorf WR, Darwish N, Glaeser E, Gaab MR. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurg Rev 2002; 25 (4) 228-230
- 13 Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL. Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 2002; 5 (1) 16-24
- 14 Butler C, Campbell S ; AACPDM Treatment Outcomes Committee Review Panel. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000; 42 (9) 634-645
- 15 Dimitrijevic MR, Sherwood AM. Spasticity: medical and surgical treatment. Neurology 1980; 30 (7 Pt 2) 19-27
- 16 Esquenazi A, Albanese A, Chancellor MB , et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon 2013; 67: 115-128
- 17 Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Neurol Sci 2005; 26 (1) 32-39
- 18 Borg-Stein J, Pine ZM, Miller JR, Brin MF. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations. Am J Phys Med Rehabil 1993; 72 (6) 364-368
- 19 Cameron MH, Bethoux F, Davis N, Frederick M. Botulinum toxin for symptomatic therapy in multiple sclerosis. Curr Neurol Neurosci Rep 2014; 14 (8) 463
- 20 Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis. Arq Neuropsiquiatr 2005; 63 (1) 30-33
- 21 Kabus C, Hecht M, Japp G , et al. Botulinum toxin in patients with multiple sclerosis. J Neurol 2006; 253 (Suppl. 01) I26-I28
- 22 Wasiak J, Hoare B, Wallen M. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Cochrane Database Syst Rev 2004; (4) CD003469
- 23 Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology 1996; 47 (4) 939-944
- 24 Kheder A, Nair KP. Spasticity: pathophysiology, evaluation and management. Pract Neurol 2012; 12 (5) 289-298
- 25 Nalysnyk L, Papapetropoulos S, Rotella P, Simeone JC, Alter KE, Esquenazi A. OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review. BMC Neurol 2013; 13: 118
- 26 Sakzewski L, Ziviani J, Boyd R. Systematic review and meta-analysis of therapeutic management of upper-limb dysfunction in children with congenital hemiplegia. Pediatrics 2009; 123 (6) e1111-e1122
- 27 Keenan MA, Haider TT, Stone LR. Dynamic electromyography to assess elbow spasticity. J Hand Surg Am 1990; 15 (4) 607-614
- 28 Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997; 6: S92-S120
- 29 Pennington L, Goldbart J, Marshall J. Speech and language therapy to improve the communication skills of children with cerebral palsy. Cochrane Database Syst Rev 2004; (2) CD003466
- 30 Aisen ML, Kerkovich D, Mast J , et al. Cerebral palsy: clinical care and neurological rehabilitation. Lancet Neurol 2011; 10 (9) 844-852
- 31 Thomason P, Selber P, Graham HK. Single event multilevel surgery in children with bilateral spastic cerebral palsy: a 5 year prospective cohort study. Gait Posture 2013; 37 (1) 23-28
- 32 Gough M, Eve LC, Robinson RO, Shortland AP. Short-term outcome of multilevel surgical intervention in spastic diplegic cerebral palsy compared with the natural history. Dev Med Child Neurol 2004; 46 (2) 91-97
- 33 Caldwell C, Braun RM. Spasticity in the upper extremity. Clin Orthop Relat Res 1974; (104) 80-91
- 34 Haefeli M, Calcagni M. [Hemiplegia and cerebral palsy - multidisciplinary treatment of the spastic upper extremity]. Praxis (Bern 1994) 2014; 103 (19) 1133-1139
- 35 Mital MA. Lengthening of the elbow flexors in cerebral palsy. J Bone Joint Surg Am 1979; 61 (4) 515-522
- 36 Manske PR, Langewisch KR, Strecker WB, Albrecht MM. Anterior elbow release of spastic elbow flexion deformity in children with cerebral palsy. J Pediatr Orthop 2001; 21 (6) 772-777
- 37 Gong HS, Cho HE, Chung CY, Park MS, Lee HJ, Baek GH. Early results of anterior elbow release with and without biceps lengthening in patients with cerebral palsy. J Hand Surg Am 2014; 39 (5) 902-909
- 38 Nath RK, Somasundaram C. Significant improvement in nerve conduction, arm length, and upper extremity function after intraoperative electrical stimulation, neurolysis, and biceps tendon lengthening in obstetric brachial plexus patients. J Orthop Surg 2015; 10: 51
- 39 Keenan MA. Management of the spastic upper extremity in the neurologically impaired adult. Clin Orthop Relat Res 1988; (233) 116-125
- 40 Morrey BF. Surgical treatment of extraarticular elbow contracture. Clin Orthop Relat Res 2000; (370) 57-64
- 41 Gschwind CR. Surgical management of forearm pronation. Hand Clin 2003; 19 (4) 649-655
- 42 Metsaars WP, Nagels J, Pijls BG, Langenhoff JM, Nelissen RG. Treatment of supination deformity for obstetric brachial plexus injury: a systematic review and meta-analysis. J Hand Surg Am 2014; 39 (10) 1948-1958.e2